发明公开
EP0156233A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions
失效
用于生产细胞保护的药物组合物和用于生产的细胞保护的药物组合物的方法的使用白三烯拮抗剂的。
- 专利标题： Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions
- 专利标题（中）： 用于生产细胞保护的药物组合物和用于生产的细胞保护的药物组合物的方法的使用白三烯拮抗剂的。
-
申请号： EP85102787.0申请日： 1985-03-12
-
公开(公告)号： EP0156233A2公开(公告)日： 1985-10-02
- 发明人: Goldenberg, Marvin M.
- 申请人： Merck & Co., Inc.
- 申请人地址： 126, East Lincoln Avenue P.O. Box 2000 Rahway New Jersey 07065-0900 US
- 专利权人： Merck & Co., Inc.
- 当前专利权人： Merck & Co., Inc.
- 当前专利权人地址： 126, East Lincoln Avenue P.O. Box 2000 Rahway New Jersey 07065-0900 US
- 代理机构： Blum, Rudolf Emil Ernst
- 优先权： US590815 19840319; US685102 19841221
- 主分类号： A61K31/35
- IPC分类号： A61K31/35
摘要：
Leukotriene antagonists have been found to be useful for inducing cytoprotection via an unspecified mechanism. Specific therapeutic utilities include, erosive gastritis, erosive esophagitis, inflammatory bowel disease, and induced hemorrhagic gastric erosions such as those caused by indomethacin or ethanol.
The leukotriene antagonists are used to produce cytoprotective pharmaceutical compositions. In a process for producing cytoprotective pharmaceutical compositions the leukotriene antagonists are incorporated into a corresponding composition in a cytoprotective effective amount.
The leukotriene antagonists are used to produce cytoprotective pharmaceutical compositions. In a process for producing cytoprotective pharmaceutical compositions the leukotriene antagonists are incorporated into a corresponding composition in a cytoprotective effective amount.
信息查询
